Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Sarcopenia in Lung Transplant Patients
EF 2014-15
Résumé
BACKGROUND/RATIONALE: Lung transplantation (LTx) is known to save lives and is increasingly performed in older patients and those at risk for limb muscle dysfunction. Muscle dysfunction is common in advanced lung disease and is defined by loss of muscle mass, strength or function. Muscle dysfunction has been associated with worse outcomes in liver and kidney transplant recipients but has not been studied in LTx before. In about one third of LTx recipients with longer than normal stays in the intensive care unit (ICU) of 7 days or more, muscle dysfunction may be an even greater problem. We know from studies on other patients with long ICU stays, that muscle dysfunction can develop and its effects can last even 2 years after leaving the ICU.
AIM: Study the effect of pre-transplant muscle health on exercise capacity, quality of life, and clinical outcomes up to 2 years post-transplant in LTx patients with long ICU stays.
ANTICIPATED OUTCOMES: LTx candidates with muscle dysfunction will have significantly reduced exercise capacity, quality of life, and worse clinical outcomes.
METHODS: 80 LTx recipients with prolonged ICU stay have been asked to participate in an ongoing study that assesses their quality of life, exercise capacity, and clinical outcomes every 3 months up to 2 years after transplant. Muscle strength and function will be taken from exercise training during chart review and muscle mass will be quantified using a novel chest imaging technique. The association of muscle dysfunction and transplant outcomes will be analyzed.
SIGNIFICANCE: This project will help understand the impact of muscle health on long term outcomes in patients undergoing LTx. It will help doctors and researchers develop new strategies to improve muscle health. The findings from this study could be applied to other populations suffering from muscle dysfunction: elderly, other organ transplants, and ICU patients.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
318259
Name
Rozenberg Dmitry
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Sarcopenia in Lung Transplant Patients
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Clinical Outcomes; Musculoskeletal Health; Physical Function; Quality Of Life; Respiratory Disease; Transplantation
Abstract
BACKGROUND/RATIONALE: Lung transplantation (LTx) is known to save lives and is increasingly performed in older patients and those at risk for limb muscle dysfunction. Muscle dysfunction is common in advanced lung disease and is defined by loss of muscle mass, strength or function. Muscle dysfunction has been associated with worse outcomes in liver and kidney transplant recipients but has not been studied in LTx before. In about one third of LTx recipients with longer than normal stays in the intensive care unit (ICU) of 7 days or more, muscle dysfunction may be an even greater problem. We know from studies on other patients with long ICU stays, that muscle dysfunction can develop and its effects can last even 2 years after leaving the ICU.
AIM: Study the effect of pre-transplant muscle health on exercise capacity, quality of life, and clinical outcomes up to 2 years post-transplant in LTx patients with long ICU stays.
ANTICIPATED OUTCOMES: LTx candidates with muscle dysfunction will have significantly reduced exercise capacity, quality of life, and worse clinical outcomes.
METHODS: 80 LTx recipients with prolonged ICU stay have been asked to participate in an ongoing study that assesses their quality of life, exercise capacity, and clinical outcomes every 3 months up to 2 years after transplant. Muscle strength and function will be taken from exercise training during chart review and muscle mass will be quantified using a novel chest imaging technique. The association of muscle dysfunction and transplant outcomes will be analyzed.
SIGNIFICANCE: This project will help understand the impact of muscle health on long term outcomes in patients undergoing LTx. It will help doctors and researchers develop new strategies to improve muscle health. The findings from this study could be applied to other populations suffering from muscle dysfunction: elderly, other organ transplants, and ICU patients.
Competitiondate
201411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Rozenberg, Dmitry
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~